Wondering how single-cell spatial transcriptomics can fit into and support drug development pipelines?
Alban Bessède, PhD, CEO of Explicyte, and Paloma Cejas, PhD, Chief of Biology at Cure51, will share their insights during a webinar organized by 10x Genomics on September 30th, 2025:
“Xenium for drug development: Analyzing cancer survivors, profiling lead compounds.”
👉 Join us for this webinar!
Discover our expertise: